Erythroleukemia and RAEB-t: A same disease? [11]

Leukemia

Volumn 18, Issue 4, 2004, Pages 888-890

  Park, Sophie ^a   Picard, F ^a   Guesnu, M ^a   Maloum, K ^b   Leblond, V ^b   Dreyfus, F ^a  

^a AP HP ^*  (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE;

ADULT; AGED; BONE MARROW TRANSPLANTATION; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ERYTHROBLAST; ERYTHROLEUKEMIA; FEMALE; HUMAN; KARYOTYPING; LETTER; LEUKEMIA REMISSION; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION; SURVIVAL TIME; CLASSIFICATION; COMPARATIVE STUDY; MIDDLE AGED; REFRACTORY ANEMIA WITH EXCESS BLASTS; SURVIVAL;

AGED; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 16544381366     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403316     Document Type: Letter

References (8)

1. Di Guglielmo G. Le Malattie Eritremiche ed Eritroleucemiche. Rome, 1962.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukaemia. A report of the French-American-British cooperative group. Ann Intem Med 1985; 103: 620-625.
3. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al, Bloomfield CD The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000; 36: 69-86.
4. Cuneo A, van Orshoven A, Michaux JL, Boogaerts M, Louwagie A, Doyen C et al. Morphologic, immunologic and cytogenetic studies in erythroleukaemia: evidence for multilineage involvement and identification of two distinct cytogenetic-clinicopathological types. Br J Haematol 1990; 75: 346-354.
5. Davey FR, Abraham NJR, Brunetto VL, Mac Gallum JM, Nelson DA, Ball ED et al. Morphologic characterisitics of erythroleukaemia (acute myeloid leukaemia; FAB-M6): a CALGB study. Am J Hematol 1995; 49: 29-38.
6. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnosis cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 Trial. Blood 1998; 92: 2322-2333.
7. Greenberg P, Cox C, Lebeau M, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
8. Mazzella FM, Kowal-Vern A, Shrit MA, Wibowo AL, Rector JT, Cotelingam JD et al. Acute erythroleukaemia: evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis. Am J Clin Pathol 1998; 110: 590-598.